Managing antipsychotic-related sexual dysfunction in patients with schizophrenia

References

• Jauhar S, Johnstone M, McKenna P. Schizophrenia. Lancet. 2022;399(10323):473–486. doi: 10.1016/S0140-6736(21)01730-X
   PubMed Web of Science ®Google Scholar
• McCutcheon RA, Marques TR, Howes OD. Schizophrenia—an overview. JAMA Psychiatry. 2020;77(2):201–210. doi: 10.1001/jamapsychiatry.2019.3360
   PubMed Web of Science ®Google Scholar
• Saha S, Chant D, Welham J, Hyman SE, et al. A systematic review of the prevalence of schizophrenia. PLOS Med. 2005;2(5):e141
   PubMed Web of Science ®Google Scholar
• Andreasen NC. The lifetime trajectory of schizophrenia and the concept of neurodevelopment. Dialogues Clin Neurosci. 2010;12(3):409–415. doi: 10.31887/DCNS.2010.12.3/nandreasen
   PubMedGoogle Scholar
• Cloutier M, Aigbogun MS, Guerin A, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry. 2016;77(6):764–771. doi: 10.4088/JCP.15m10278
   PubMed Web of Science ®Google Scholar
• Hjorthøj C, Stürup AE, Mcgrath JJ, et al. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301
   PubMed Web of Science ®Google Scholar
• de Boer MK, Castelein S, Wiersma D, et al. The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings. Schizophr Bull. 2015;41(3):674–686. doi: 10.1093/schbul/sbv001
   PubMed Web of Science ®Google Scholar
• Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol. 2008 Apr;23(3):201–209. doi: 10.1002/hup.924
   PubMed Web of Science ®Google Scholar
• Chen L, Shi GR, Huang DD, et al. Male sexual dysfunction: a review of literature on its pathological mechanisms, potential risk factors, and herbal drug intervention. Biomed Pharmacother. 2019;112:108585. doi: 10.1016/j.biopha.2019.01.046
   PubMed Web of Science ®Google Scholar
• Jha S, Thakar R. Female sexual dysfunction. Eur J Obstet Gynecol Reprod Biol. 2010;153(2):117–123. doi: 10.1016/j.ejogrb.2010.06.010
   PubMed Web of Science ®Google Scholar
• Trajanovska AS, Vujovic V, Ignjatova L, et al. Sexual dysfunction as a side effect of hyperprolactinemia in methadone maintenance therapy Med. Med Arh. 2013;67(1):48–50
   Google Scholar
• Gerra G, Manfredini M, Somaini L, et al. Sexual dysfunction in men receiving methadone maintenance treatment: clinical history and psychobiological correlates. Eur Addict Res. 2016;22(3):163–175. doi: 10.1159/000441470
   PubMed Web of Science ®Google Scholar
• Ujah GA, Nna VU, Agah MI, et al. Effect of quercetin on cadmium chloride-induced impairments in sexual behaviour and steroidogenesis in male Wistar rats. Andrologia. 2018;50(2):e12866
   Web of Science ®Google Scholar
• Malviya N, Malviya S, Jain S, et al. A review of the potential of medicinal plants in the management and treatment of male sexual dysfunction. Andrologia. 2016;48(8):880–893
   PubMed Web of Science ®Google Scholar
• Sheweita SA, Wally M, Hassan M. Erectile dysfunction drugs changed the protein expressions and activities of drug-metabolising enzymes in the liver of male rats oxid. Med Cell Longev. 2016;2016:4970906. doi: 10.1155/2016/4970906
   PubMed Web of Science ®Google Scholar
• Smith SM, O’Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry. 2002;181:49–55. doi: 10.1192/bjp.181.1.49
   PubMed Web of Science ®Google Scholar
• Jannini TB, Sansone A, Rossi R, et al. Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment. Expert Opin Pharmacother. 2022;23(9):1065–1080. doi: 10.1080/14656566.2022.2071124
   PubMed Web of Science ®Google Scholar
• During SW, Nielsen MO, Bak N, et al. Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2/3 receptor blockade - an exploratory study. Psychiatry Res. 2019;274:58–65. doi: 10.1016/j.psychres.2019.02.017
   PubMed Web of Science ®Google Scholar
• Montejo AL, Montejo L, Navarro-Cremades F. Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry. 2015;28(6):418–423. doi: 10.1097/YCO.0000000000000198
   PubMed Web of Science ®Google Scholar
• Toscano M, Vigano A, Puledda F, et al. Serotonergic correlation with anger and aggressive behavior in acute stroke patients: an intensity dependence of auditory evoked potentials (IDAP) study. Eur Neurol. 2014;72(3–4):186–192. doi: 10.1159/000362268
   PubMed Web of Science ®Google Scholar
• Aizenberg D, Zemishlany Z, Dorfman-Etrog P, et al. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry. 1995;56(4):137–141.
   PubMed Web of Science ®Google Scholar
• Cutler AJ. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology. 2003;28(suppl 1):69–82. doi: 10.1016/s0306-4530(02)00113-0
   PubMedGoogle Scholar
• Knegtering H, van der Moolen AE, Castelein S, et al. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology. 2003;28(suppl 2):109–123. doi: 10.1016/s0306-4530(02)00130-0
   PubMed Web of Science ®Google Scholar
• Meaney AM, O’Keane V. Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia. Life Sci. 2002;71(9):979–992. doi: 10.1016/s0024-3205(02)01775-7
   PubMed Web of Science ®Google Scholar
• Dossenbach M, Hodge A, Anders M, et al. Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol. 2005;8(2):195–201
   PubMed Web of Science ®Google Scholar
• Raboch J. The sexual development and life of female schizophrenic patients. Arch Sex Behav. 1984;13(4):341–349. doi: 10.1007/BF01541906
   PubMed Web of Science ®Google Scholar
• Lyketsos GC, Sakka P, Maïlis A. The sexual adjustment of chronic schizophrenics: a preliminary study. Br J Psychiatry. 1983;143(4):376–382. doi: 10.1192/bjp.143.4.376
   PubMedGoogle Scholar
• Kremen WS, Seidman LJ, Faraone SV, et al. The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol. 2000;109(4):743–752
   PubMed Web of Science ®Google Scholar
• Weickert TW, Goldberg TE, Gold JM, et al. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry. 2000;57(9):907–913. doi: 10.1001/archpsyc.57.9.907
   PubMed Web of Science ®Google Scholar
• MacCabe JH, Brébion G, Reichenberg A, et al. Superior intellectual ability in schizophrenia: neuropsychological characteristics. Neuropsychology. 2012;26(2):181–190. doi: 10.1037/a0026376
   PubMed Web of Science ®Google Scholar
• Cunningham Owens DG, Johnstone EC. The disabilities of chronic schizophrenia—their nature and the factors contributing to their development. Br J Psychiatry. 1980;136(4):384–395. doi: 10.1192/bjp.136.4.384
   PubMedGoogle Scholar
• Palmer BW, Dawes SE, Heaton RK. What do we know about neuropsychological aspects of schizophrenia? Neuropsychol rev. 2009;19(3):365–384. doi: 10.1007/s11065-009-9109-y
   PubMed Web of Science ®Google Scholar
• Reichenberg A. The assessment of neuropsychological functioning in schizophrenia. Dialogues Clin Neurosci. 2010;12(3):383–392. doi: 10.31887/DCNS.2010.12.3/areichenberg
   PubMedGoogle Scholar
• Abel KM, Drake R, Goldstein JM. Sex differences in schizophrenia. Int Rev Psychiatry. 2010;22(5):417–428. doi: 10.3109/09540261.2010.515205
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Bardenstein KK. Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr Bull. 1990;16(2):319–329. doi: 10.1093/schbul/16.2.319
   PubMed Web of Science ®Google Scholar
• Jacobs P, Bobek SC. Sexual needs of the schizophrenic client. Perspect Psychiatr Care. 2009;27(1):15–20. doi: 10.1111/j.1744-6163.1991.tb00328.x
   Google Scholar
• Akhtar S, Thomson JA. Jr schizophrenia and sexuality: a review and a report of twelve unusual cases–part II. J Clin Psychiatry. 1980;41(5):166–174.
   PubMed Web of Science ®Google Scholar
• Connolly FH, Gittleson NL. The relationship between delusions of sexual change and olfactory and gustatory hallucinations in schizophrenia. Br J Psychiatry. 1971;119(551):443–444. doi: 10.1192/bjp.119.551.443
   PubMed Web of Science ®Google Scholar
• Park YW, Kim Y, Lee JH. Antipsychotic-induced sexual dysfunction and its management. World J Mens Health. 2012;30(3):153–159. doi: 10.5534/wjmh.2012.30.3.153
   PubMedGoogle Scholar
• de Bartolomeis A, Tomasetti C, Iasevoli F. Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism. CNS Drugs. 2015;29(9):773–799. doi: 10.1007/s40263-015-0278-3
   PubMed Web of Science ®Google Scholar
• Fujioi J, Iwamoto K, Banno M, et al. Effect of adjunctive aripiprazole on sexual dysfunction in schizophrenia: a preliminary open-label study. Pharmacopsychiatry. 2016;50(2):74–78
   PubMed Web of Science ®Google Scholar
• Jackson IM. Thyrotropin-releasing hormone. N Engl J Med. 1982;306(3):145–155. doi: 10.1056/NEJM198201213060305
   PubMed Web of Science ®Google Scholar
• Freeman ME, Kanyicska B, Lerant A, et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80(4):1523–1631
   PubMed Web of Science ®Google Scholar
• Melmed S, Auchus RJ, Goldfine AB, et al. Williams textbook of endocrinology. 14. Philadelphia: Elsevier, Inc. Acta Endocrinologica (Bucharest). 2019;15(3):416. doi: 10.4183/aeb.2019.416
   Google Scholar
• White JM, Rumbold GR. Behavioural effects of histamine and its antagonists: a review. Psychopharmacol (Berl). 1988;95(1):1–14. doi: 10.1007/BF00212757
   PubMed Web of Science ®Google Scholar
• Mollaioli D, Ciocca G, Limoncin E, et al. Lifestyles and sexuality in men and women: the gender perspective in sexual medicine. Reprod Biol Endocrinol. 2020;18(1):10
   PubMed Web of Science ®Google Scholar
• Kaar SJ, Natesan S, McCutcheon R, et al. Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 2020;172:107704. doi: 10.1016/j.neuropharm.2019.107704
   PubMed Web of Science ®Google Scholar
• Mailman RB, Murthy V. Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr Pharm Des. 2010;16(5):488–501. doi: 10.2174/138161210790361461
   PubMed Web of Science ®Google Scholar
• Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373(9657):31–41
   PubMed Web of Science ®Google Scholar
• Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol Behav. 2004;83(2):291–307. doi: 10.1016/j.physbeh.2004.08.018
   PubMed Web of Science ®Google Scholar
• Macdonald S, Halliday J, Mac ET, et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-Control Study. Br J Psychiatry. 2003;182(1):50–56
   PubMedGoogle Scholar
• Ichinose T, Tanimoto H, Yamagata N. Behavioral modulation by spontaneous activity of dopamine neurons. Front Syst Neurosci. 2017;11:88. doi: 10.3389/fnsys.2017.00088
   PubMed Web of Science ®Google Scholar
• Tharoor H, Kaliappan A, Gopal S. Sexual dysfunctions in schizophrenia - professionals and patients perspectives. Indian J Psychiatry. 2015;57(1):85–87. doi: 10.4103/0019-5545.148532
   PubMed Web of Science ®Google Scholar
• Seitz T, Ucsnik L, Kottmel A, et al. Let us integrate sexual health—do psychiatrists integrate sexual health in patient management? Arch Womens Ment Health. 2020;23(4):527–534
   PubMed Web of Science ®Google Scholar
• Lukoff D, Gioia-Hasick D, Sullivan G, et al. Sex education and rehabilitation with schizophrenic male outpatients. Schizophr Bull. 1986;12(4):669–677
   PubMed Web of Science ®Google Scholar
• Sansone A, Sansone M, Vaamonde D, et al. Sport, doping and male fertility. Reprod Biol Endocrinol. 2018;16(1):114. doi: 10.1186/s12958-018-0435-x
   PubMedGoogle Scholar
• Sansone A, Mollaioli D, Ciocca G, et al. Sexual dysfunction in men and women with diabetes: a mirror of their complications? Curr Diabetes Rev. 2022;18(1):e030821192147
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Morelli A, et al. Treatment of functional hypogonadism besides pharmacological substitution. World J Mens Health. 2020;38(3):256–270. doi: 10.5534/wjmh.190061
   PubMedGoogle Scholar
• Jauhar S, McKenna P, Radua J, et al. Cognitive–behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014;204(1):20–29. doi: 10.1192/bjp.bp.112.116285
   PubMed Web of Science ®Google Scholar
• Donaldson JF, Rees RW, Steinbrecher HA. Priapism in children: a comprehensive review and clinical guideline. J Pediatr Urol. 2014;10(1):11–24. doi: 10.1016/j.jpurol.2013.07.024
   PubMed Web of Science ®Google Scholar
• Montejo AL, de Alarcón R, Prieto N, et al. Management strategies for antipsychotic-related sexual dysfunction: a clinical approach. J Clin Med. 2021;10(2):308. doi: 10.3390/jcm10020308
   PubMed Web of Science ®Google Scholar
• Hummer M, Kemmler G, Kurz M, et al. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry. 1999;156(4):631–633
   PubMed Web of Science ®Google Scholar
• Costa AM, Lima MS, Mari Jde J. A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia. Sao Paulo Med J. 2006;124(5):291–297. doi: 10.1590/s1516-31802006000500012
   PubMedGoogle Scholar
• Downing L, Kim DD, Procyshyn RM, et al. Management of sexual adverse effects induced by atypical antipsychotic medication. J Psychiatry Neurosci. 2019;44(4):287–288
   PubMed Web of Science ®Google Scholar
• La Torre A, Conca A, Duffy D, et al. Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics. Pharmacopsychiatry. 2013;46(6):201–208. doi: 10.1055/s-0033-1347177
   PubMed Web of Science ®Google Scholar
• Montejo AL, Montejo L, Baldwin DS. The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry. 2018;17(1):3–11. doi: 10.1002/wps.20509
   PubMed Web of Science ®Google Scholar
• Montejo AL, Riesgo Y, Luque J, et al. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole. Actas Esp Psiquiatr 2010;38(1):13–21.
   PubMed Web of Science ®Google Scholar
• Hanssens L, L’Italien G, Loze JY, et al. The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the schizophrenia trial of aripiprazole (STAR) study (NCT00237913). BMC Psychiatry. 2008;8(95). doi: 10.1186/1471-244X-8-95
   PubMedGoogle Scholar
• Basson R, Rees P, Wang R, et al. Sexual function in chronic illness. J Sex Med. 2010;7(1 Pt 2):374–388
   PubMed Web of Science ®Google Scholar
• Basson R, Gilks T. Women’s sexual dysfunction associated with psychiatric disorders and their treatment. Women’s Health. 2018;14:14. doi: 10.1177/1745506518762664
   Google Scholar
• Nunes LV, Moreira HC, Razzouk D, et al. Kneg strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review. J Sex Marital Ther. 2012;38(3):281–301
   PubMed Web of Science ®Google Scholar
• Schmidt HM, Hagen M, Kriston L, et al. Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev. 2012;11(11):CD003546
   PubMedGoogle Scholar
• Nakonezny PA, Byerly MJ, Rush AJ. The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine. J Sex Marital Ther. 2007;33(3):203–216. doi: 10.1080/00926230701267829
   PubMed Web of Science ®Google Scholar
• Ivkovic J, Lindsten A, George V, et al. Effect of brexpiprazole on prolactin: an analysis of short- and long-term studies in schizophrenia. J Clin Psychopharmacol. 2019;39(1):13–19. doi: 10.1097/JCP.0000000000000979
   PubMed Web of Science ®Google Scholar
• Jeong HG, Lee MS, Lee HY, et al. Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study. Int Clin Psychopharmacol. 2012;27(4):177–183
   PubMed Web of Science ®Google Scholar
• Montejo AL, Rico-Villademoros F, Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study. J Clin Psychopharmacol. 2008;28(5):568–570. doi: 10.1097/JCP.0b013e31818501a1
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram N, Nivedhya J, Karthik MS, et al. Risperidone-induced retrograde ejaculation and lurasidone may be the alternative. Indian J Psychiatry. 2019;28(1):152–154
   Google Scholar
• Mir A, Shivakumar K, Williamson RJ, et al. Change in sexual dysfunction with aripiprazole: a switching or add-on study. J Psychopharmacol. 2008;22(3):244–253
   PubMed Web of Science ®Google Scholar
• Kane JM, Zukin S, Wang Y, et al. Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial. 81107082901. J Clin Psychopharmacol. 2015;35(4):367–373. doi: 10.1097/JCP.0000000000000346
   PubMed Web of Science ®Google Scholar
• Montejo González AL, Rico-Villademoros F, Tafalla M, et al. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. A 6-month prospective observational study on the effects of quetiapine on sexual functioning. J Clin Psychopharmacol. 2005;25(6):533–538.
   PubMed Web of Science ®Google Scholar
• Keller R, Mongini F. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurol Sci. 2002;23(5):233–235. doi: 10.1007/s100720200047
   PubMed Web of Science ®Google Scholar
• de Boer MK, Oolders JM, van den Heuvel ER, et al. Efficacy of tadalafil on erectile dysfunction in male patients using antipsychotics: a double-blind, placebo-controlled, crossover pilot study. J Clin Psychopharmacol. 2014;34(3):380–382. doi: 10.1097/JCP.0000000000000113
   PubMed Web of Science ®Google Scholar
• Nunes LV, Dieckmann LHL, Lacaz FS, et al. Estratégia de manejo para a disfunção sexual induzida por antipsicóticos: descrição de um relato de caso. Braz J Psychiatry. 2008;30(3):296–297
   PubMedGoogle Scholar
• Mitsonis CI, Mitropoulos PA, Dimopoulos NP, et al. Vardenafil in the treatment of erectile dysfunction in outpatients with chronic schizophrenia: a flexible-dose, open-label study. J Clin Psychiatry. 2008;69(2):206–212. doi: 10.4088/jcp.v69n0206
   PubMed Web of Science ®Google Scholar
• Nunes LV, Lacaz FS, Bressan RA, et al. Adjunctive treatment with lodenafil carbonate for erectile dysfunction in outpatients with schizophrenia and spectrum: a randomized, double-blind, crossover, placebo-controlled trial. J Sex Med. 2013;10(4):1136–1145
   PubMed Web of Science ®Google Scholar
• Terevnikov V, Joffe G, Stenberg JH. Randomized controlled trials of add-on antidepressants in schizophrenia. Int J Neuropsychopharmacol. 2015;18(9):pyv049. doi: 10.1093/ijnp/pyv049
   PubMed Web of Science ®Google Scholar
• Gitlin M. Sexual dysfunction with psychotropic drugs. Expert Opin Pharmacother. 2003;4(12):2259–2269. doi: 10.1517/14656566.4.12.2259
   PubMed Web of Science ®Google Scholar
• Clayton AH, Alkis AR, Parikh NB, et al. Sexual dysfunction due to psychotropic medications. Psychiatr Clin North Am. 2016;39(3):427–463
   PubMed Web of Science ®Google Scholar
• Barabássy Á, Sebe B, Acsai K, et al. Safety and tolerability of cariprazine in patients with schizophrenia: a pooled analysis of eight Phase II/III studies. Neuropsychiatr Dis Treat. 2021;17:957–970. doi: 10.2147/NDT.S301225
   PubMed Web of Science ®Google Scholar
• Liu-Seifert H, Kinon BJ, Tennant CJ, et al. Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone. Neuropsychiatr Dis Treat. 2009;5:47–54. doi: 10.2147/ndt.s4766
   PubMed Web of Science ®Google Scholar
• Crawford MJ, Thana L, Evans R, et al. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT. Health Technol Assess. 2020;24(44):1–54
   Web of Science ®Google Scholar
• de Boer MK, Wiersma D, Bous J, et al. A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). J Clin Psychopharmacol. 2011;31(4):523–525. doi: 10.1097/JCP.0b013e318222bb29
   PubMed Web of Science ®Google Scholar
• Fanta T, Haile K, Abebaw D, et al. Assessment of sexual dysfunction and associated factors among patients with schizophrenia in Ethiopia, 2017. BMC Psychiatry. 2018;18(1):158. doi: 10.1186/s12888-018-1738-3
   PubMedGoogle Scholar
• Strien AM, Keijsers CJ, Derijks HJ, et al. Rating scales to measure side effects of antipsychotic medication: a systematic review. J Psychopharmacol. 2015;29(8):857–866. doi: 10.1177/0269881115593893
   PubMed Web of Science ®Google Scholar
• Rossi A, Vita A, Tiradritti P, et al. Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone. Int Clin Psychopharmacol. 2008;23(4):216–222
   PubMed Web of Science ®Google Scholar